![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/444 | (2006.01) |
A61K 31/444 | (2013.01) | ||
A61K 31/506 | (2006.01) | ||
A61K 31/517 | (2013.01) | ||
A61K 45/00 | (2006.01) | ||
A61K 31/5377 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 35/02 | (2006.01) | ||
A61K 45/06 | (2013.01) | ||
A61P 43/00 | (2006.01) | ||
A61K 31/517 | (2006.01) | ||
A61K 31/5377 | (2006.01) | ||
A61K 45/06 | (2006.01) |
(11) | Number of the document | 3603638 |
(13) | Kind of document | T |
(96) | European patent application number | 18770641.1 |
Date of filing the European patent application | 2018-03-23 | |
(97) | Date of publication of the European application | 2020-02-05 |
(45) | Date of publication and mention of the grant of the patent | 2023-12-13 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2018/011560 |
Date | 2018-03-23 |
(87) | Number | WO 2018/174219 |
Date | 2018-09-27 |
(30) | Number | Date | Country code |
2017058858 | 2017-03-24 | JP |
(72) |
JIMBO, Takeshi , JP
|
(73) |
Daiichi Sankyo Company, Limited ,
3-5-1, Nihonbashi-honcho
Chuo-ku, Tokyo 103-8426,
JP
|
(54) | COMBINATION THERAPY TECHNIQUE FOR AXL INHIBITORY AGENT AND EGFR TYROSINE KINASE INHIBITOR |
COMBINATION THERAPY TECHNIQUE FOR AXL INHIBITORY AGENT AND EGFR TYROSINE KINASE INHIBITOR |